blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3628731

EP3628731 - NOVEL ANTI-PRESEPSIN ANTIBODY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.02.2022
Database last updated on 16.11.2024
FormerThe patent has been granted
Status updated on  19.03.2021
FormerGrant of patent is intended
Status updated on  09.12.2020
FormerRequest for examination was made
Status updated on  25.09.2020
FormerThe application has been published
Status updated on  28.02.2020
Most recent event   Tooltip27.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 30.10.2024  [2024/44]
Applicant(s)For all designated states
Mochida Pharmaceutical Co., Ltd.
7 Yotsuya 1-chome Shinjuku-ku
Tokyo 160-8515 / JP
[2020/14]
Inventor(s)01 / SHIRAKAWA, Kamon
c/o Mochida Pharmaceutical Co., Ltd.
7 Yotsuya 1-chome
Shinjuku-ku
Tokyo 160-8515 / JP
 [2020/14]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[2020/14]
Application number, filing date19188513.625.02.2015
[2020/14]
Priority number, dateUS201461944674P26.02.2014         Original published format: US 201461944674 P
[2020/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3628731
Date:01.04.2020
Language:EN
[2020/14]
Type: B1 Patent specification 
No.:EP3628731
Date:21.04.2021
Language:EN
[2021/16]
Search report(s)(Supplementary) European search report - dispatched on:EP20.12.2019
ClassificationIPC:C12N15/09, C07K16/28, C12N5/10, G01N33/53
[2020/14]
CPC:
C07K16/2896 (EP,KR,US); C07K16/18 (RU); G01N33/6893 (EP,KR,RU,US);
A61K2039/505 (US); C07K2317/14 (EP,KR,US); C07K2317/33 (KR,US);
C07K2317/34 (EP,KR,US); C07K2317/565 (EP,KR,US); C07K2317/76 (KR,US);
C07K2317/92 (EP,KR,US); G01N2333/70596 (EP,KR,US); G01N2800/26 (EP,KR,US);
G01N33/569 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/44]
Former [2020/14]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:NEUARTIGE ANTI-PRESEPSIN-ANTIKÖRPER[2020/14]
English:NOVEL ANTI-PRESEPSIN ANTIBODY[2020/14]
French:NOUVEL ANTICORPS ANTI-PRÉSEPSINE[2020/14]
Examination procedure22.09.2020Amendment by applicant (claims and/or description)
22.09.2020Examination requested  [2020/44]
22.09.2020Date on which the examining division has become responsible
10.12.2020Communication of intention to grant the patent
12.03.2021Fee for grant paid
12.03.2021Fee for publishing/printing paid
12.03.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP15755779.4  / EP3112463
Opposition(s)24.01.2022No opposition filed within time limit [2022/13]
Fees paidRenewal fee
26.07.2019Renewal fee patent year 03
26.07.2019Renewal fee patent year 04
26.07.2019Renewal fee patent year 05
05.02.2020Renewal fee patent year 06
25.02.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.02.2015
AL21.04.2021
CY21.04.2021
DK21.04.2021
EE21.04.2021
HR21.04.2021
LV21.04.2021
MC21.04.2021
MK21.04.2021
MT21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
[2024/44]
Former [2024/25]HU25.02.2015
AL21.04.2021
CY21.04.2021
DK21.04.2021
EE21.04.2021
HR21.04.2021
LV21.04.2021
MC21.04.2021
MK21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
Former [2024/23]AL21.04.2021
CY21.04.2021
DK21.04.2021
EE21.04.2021
HR21.04.2021
LV21.04.2021
MC21.04.2021
MK21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
Former [2024/20]AL21.04.2021
CY21.04.2021
DK21.04.2021
EE21.04.2021
HR21.04.2021
LV21.04.2021
MC21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/44]AL21.04.2021
DK21.04.2021
EE21.04.2021
HR21.04.2021
LV21.04.2021
MC21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/26]AL21.04.2021
DK21.04.2021
EE21.04.2021
HR21.04.2021
LV21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/23]DK21.04.2021
EE21.04.2021
HR21.04.2021
LV21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/10]DK21.04.2021
EE21.04.2021
HR21.04.2021
LV21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
PT23.08.2021
IS22.12.2021
Former [2022/08]DK21.04.2021
HR21.04.2021
LV21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/07]HR21.04.2021
LV21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
Former [2021/51]HR21.04.2021
LV21.04.2021
BG21.07.2021
NO21.07.2021
IS21.08.2021
PT23.08.2021
Former [2021/49]HR21.04.2021
LV21.04.2021
BG21.07.2021
NO21.07.2021
Former [2021/47]BG21.07.2021
Documents cited:Search[AD]EP1571160  (MOCHIDA PHARM CO LTD [JP]);
 [AD]EP1746104  (MOCHIDA PHARM CO LTD [JP])
by applicantWO2004044005
 WO2005108429
 JP2007215546
 US7429487
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.